Invest in Kezar Life Sciences Inc on Stash
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company.
Ticker: KZR
Kezar Life Sciences Inc
$7.42
+15.40%
$
KZR Performance Breakdown
Share Price
$7.42
Today's change
-0.4%
Year to date change (YTD)
17.97%
Dividend yield
0.0
Last dividend paid
N/A
Last dividend pay date
N/A
About KZR
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing novel small molecule therapeutics to treat autoimmune disorders, cancer, and malignant diseases. Its therapies target protein homeostasis. Its lead development program is KZR-616. KZR-616 is a selective small molecule inhibitor of the immunoproteasome. Its second program focuses on small-molecule modulators of the protein secretion pathway. Its protein secretion program is focused on the areas of oncology, inflammation and immune-oncology.
Kezar Life Sciences Inc Stock Ticker
KZR
For more information
Certain companies are volatile
Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.
Kezar Life Sciences Inc stock news
Why invest with Stash?
Fractional shares
Thousands of stocks and ETFs. No investing minimums.
Unlimited trades
Plus no add-on trading commission fees.†
Diversification analysis
Custom investment recommendations can help you diversify.
Automatic investing
Dividend reinvestment,8 recurring investments, and more.
The Stock-Back® Card
We’ll give you matching stock in companies you shop at.1
Learn how to invest
Get professional advice and education at every step.
How to buy Kezar Life Sciences Inc stock on Stash
Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
Stash offers two subscription plans: Stash Growth and Stash+.
Once your market order of Kezar Life Sciences Inc stock is complete, you'll officially be a shareholder of Kezar Life Sciences Inc!
More Health Care stocks
Apellis Pharmaceuticals Inc
135.4%
Centessa Pharmaceuticals Limited
44.02%
Precigen Inc
19.08%
Alkermes PLC
17.38%
Fulcrum Therapeutics Inc
16.57%
Praxis Precision Medicines Inc
16.55%
Mineralys Therapeutics, Inc.
15.23%
Immunitybio Inc
15.17%
Ocular Therapeutix Inc
14.46%
Agios Pharmaceuticals Inc
14.25%
Scholar Rock Holding Corp.
14.11%



